Compton Capital Management Inc Kodiak Sciences Inc. Transaction History

Compton Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$80.85 - $128.49 $177,870 - $282,678	-2,200 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$77.2 - $126.54 $15,440 - $25,308	200 Added 10.0%	2,200 $205,000
Q1 2021 May 04, 2021	BUY	$110.45 - $164.47 $27,612 - $41,117	250 Added 14.29%	2,000 $227,000
Q4 2020 Feb 08, 2021	BUY	$60.78 - $154.03 $106,365 - $269,552	1,750 New	1,750 $257,000

103

39.8M

7.6K

3.5K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $203M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Compton Capital Management Inc , based on Form 13F filings with the SEC.

Stay updated on Compton Capital Management Inc with notifications on news.